Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Aga Khan University (499)
- Thomas Jefferson University (394)
- Zucker School of Medicine at Hofstra/Northwell (334)
- Providence (215)
- University of Kentucky (194)
-
- Himmelfarb Health Sciences Library, The George Washington University (143)
- Children's Mercy Kansas City (127)
- Selected Works (125)
- University of Vermont (107)
- Western University (92)
- Lehigh Valley Health Network (68)
- West Virginia University (65)
- City University of New York (CUNY) (52)
- Universitas Indonesia (48)
- University of New Mexico (47)
- Edith Cowan University (43)
- Marshall University (42)
- Valparaiso University (37)
- University of Nebraska Medical Center (36)
- Virginia Commonwealth University (36)
- Bowling Green State University (32)
- University of South Florida (28)
- Advocate Health - Midwest (25)
- Touro College and University System (25)
- University of New England (25)
- University of Nebraska - Lincoln (24)
- Chapman University (23)
- Rowan University (23)
- Tower Health (21)
- Australian College of Perioperative Nurses (ACORN) (20)
- Keyword
-
- Humans (176)
- Female (138)
- Male (120)
- Science & Technology (109)
- Life Sciences & Biomedicine (102)
-
- Cancer (74)
- Adult (67)
- Child (61)
- Middle Aged (56)
- Vermont (52)
- Adolescent (47)
- Children (46)
- Department of Medicine (46)
- Aged (45)
- Pregnancy (42)
- Animals (40)
- Department of Medicine Faculty (36)
- Infant (36)
- Department of Medicine Fellows and Residents (35)
- Pediatrics (35)
- Immunotherapy (34)
- Internal medicine (34)
- Inflammation (32)
- Child, Preschool (31)
- Psychiatry (31)
- Surgery (29)
- Pakistan (28)
- Primary care (28)
- Young Adult (28)
- Mice (27)
- Publication
-
- Journal Articles (341)
- Articles, Abstracts, and Reports (195)
- Family Medicine Clerkship Student Projects (104)
- Department of Paediatrics and Child Health (75)
- Manuscripts, Articles, Book Chapters and Other Papers (66)
-
- Faculty & Staff Scholarship (65)
- Paediatrics Publications (59)
- Posters (48)
- Pediatrics Faculty Publications (46)
- Department of Medicine (45)
- Department of Pathology and Laboratory Medicine (44)
- Pakistan Journal of Neurological Sciences (PJNS) (44)
- Publications and Research (42)
- UNM Orthopaedic Research Journal (40)
- Research outputs 2014 to 2021 (37)
- Jurnal Penyakit Dalam Indonesia (36)
- Journal of Mind and Medical Sciences (33)
- Journal of Sports Medicine and Allied Health Sciences: Official Journal of the Ohio Athletic Trainers Association (32)
- Theses & Dissertations (32)
- Electronic Thesis and Dissertation Repository (31)
- Department of Anaesthesia (30)
- Section of Neurosurgery (30)
- The Medicine Forum (30)
- Department of Radiology (29)
- GW Research Days 2016 - 2020 (27)
- Journal of Patient-Centered Research and Reviews (25)
- Theses and Dissertations (23)
- Department of Emergency Medicine Faculty Papers (22)
- Department of Neurology Faculty Papers (22)
- Department of Pathology, Anatomy, and Cell Biology Faculty Papers (22)
Articles 3511 - 3517 of 3517
Full-Text Articles in Entire DC Network
4-Year Results From The Rapid-Psa Phase 3 Randomised Placebo-Controlled Trial Of Certolizumab Pegol In Psoriatic Arthritis., Désirée Van Der Heijde, Atul Deodhar, Oliver Fitzgerald, Roy Fleischmann, Dafna Gladman, Alice B Gottlieb, Bengt Hoepken, Lars Bauer, Oscar Irvin-Sellers, Majed Khraishi, Luke Peterson, Anthony Turkiewicz, Jürgen Wollenhaupt, Philip Mease
4-Year Results From The Rapid-Psa Phase 3 Randomised Placebo-Controlled Trial Of Certolizumab Pegol In Psoriatic Arthritis., Désirée Van Der Heijde, Atul Deodhar, Oliver Fitzgerald, Roy Fleischmann, Dafna Gladman, Alice B Gottlieb, Bengt Hoepken, Lars Bauer, Oscar Irvin-Sellers, Majed Khraishi, Luke Peterson, Anthony Turkiewicz, Jürgen Wollenhaupt, Philip Mease
Articles, Abstracts, and Reports
Objective: To report the efficacy, patient-reported, radiographic and safety outcomes of 4 years' certolizumab pegol (CZP) treatment in patients with psoriatic arthritis (PsA).
Methods: RAPID-PsA (NCT01087788) was double-blind and placebo-controlled to Week 24, dose-blind to Week 48 and open-label (OL) to Week 216. Patients were randomised 1:1:1 to either placebo or CZP 200 mg every 2 weeks (Q2W) or 400 mg every 4 weeks (Q4W) (following 400 mg at Weeks 0/2/4). Patients randomised to CZP continued their assigned dose in the OL period. Patients randomised to placebo were re-randomised to CZP 200 mg Q2W or 400 mg Q4W (post-loading dose) …
Earle A. Chiles Research Institute 2017 Year In Review, Earle A. Chiles Research Institute
Earle A. Chiles Research Institute 2017 Year In Review, Earle A. Chiles Research Institute
Articles, Abstracts, and Reports
2017 Year in Review for the Earle A. Chiles Research Institute, a division of Providence Cancer Institute at the Robert W. Franz Cancer Center. Year in Review is published annually and highlights translational immunotherapy research from the Earle A. Chiles Research Institute.
A leader in cancer immunotherapy research and innovation since 1993, the Earle A. Chiles Research Institute is a world-class research facility, and home to a team of internationally known scientists and physicians.
Baseline Patient Characteristics Associated With Response To Biologic Therapy In Patients With Psoriatic Arthritis Enrolled In The Corrona Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Chitra Karki, Mei Liu, Arthur Kavanaugh, Christopher T Ritchlin, Doquyen Hoa Huynh, Jacqueline B Palmer, Jeffrey D Greenberg
Baseline Patient Characteristics Associated With Response To Biologic Therapy In Patients With Psoriatic Arthritis Enrolled In The Corrona Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Chitra Karki, Mei Liu, Arthur Kavanaugh, Christopher T Ritchlin, Doquyen Hoa Huynh, Jacqueline B Palmer, Jeffrey D Greenberg
Articles, Abstracts, and Reports
Objectives: To compare baseline characteristics between patients with psoriatic arthritis (PsA) who achieved and did not achieve minimal disease activity (MDA) with biologic therapy in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Methods: Patients with PsA aged ≥18 years enrolled between March 2013 and March 2016 who were receiving biologics at enrolment (baseline), not in MDA and had ≥2 follow-up visits were included. Patients were classified as those who remained on their index biologic and achieved MDA at the second follow-up visit (MDA achievers (MDA-A)) and those who did not (MDA non-achievers (MDA-NA)). Demographics, clinical characteristics, patient-reported outcomes and medication history …
Current Approaches And New Developments In The Pharmacological Management Of Tourette Syndrome., Julio Quezada, Keith A. Coffman
Current Approaches And New Developments In The Pharmacological Management Of Tourette Syndrome., Julio Quezada, Keith A. Coffman
Manuscripts, Articles, Book Chapters and Other Papers
Tourette syndrome (TS) is a neurodevelopmental disorder of unknown etiology characterized by spontaneous, involuntary movements and vocalizations called tics. Once thought to be rare, TS affects 0.3-1% of the population. Tics can cause physical discomfort, emotional distress, social difficulties, and can interfere with education and desired activities. The pharmacologic treatment of TS is particularly challenging, as currently the genetics, neurophysiology, and neuropathology of this disorder are still largely unknown. However, clinical experience gained from treating TS has helped us better understand its pathogenesis and, as a result, derive treatment options. The strongest data exist for the antipsychotic agents, both typical …
Mir-29c Plays A Suppressive Role In Breast Cancer By Targeting The Timp3/Stat1/Foxo1 Pathway., Wan Li, Jie Yi, Xiangjin Zheng, Shiwei Liu, Weiqi Fu, Liwen Ren, Li Li, Dave S B Hoon, Jinhua Wang, Guanhua Du
Mir-29c Plays A Suppressive Role In Breast Cancer By Targeting The Timp3/Stat1/Foxo1 Pathway., Wan Li, Jie Yi, Xiangjin Zheng, Shiwei Liu, Weiqi Fu, Liwen Ren, Li Li, Dave S B Hoon, Jinhua Wang, Guanhua Du
Articles, Abstracts, and Reports
Background: miR-29c has been associated with the progression of many cancers. However, the function and mechanism of miR-29c have not been well investigated in breast cancers.
Methods: Real-time quantitative PCR was used to assess expression of miR-29c and DNMT3B mRNA. Western blot and immunochemistry were used to examine the expression of DNA methyltransferase 3B (DNMT3B) protein in breast cancer cells and tissues. The functional roles of miR-29c in breast cancer cells such as proliferation, migration, invasion, colony formation, and 3D growth were evaluated using MTT, transwell chambers, soft agar, and 3D Matrigel culture, respectively. In addition, the luciferase reporter assay …
Standard Ablation Versus Magnetic Resonance Imaging-Guided Ablation In The Treatment Of Ventricular Tachycardia., Tarek Zghaib, Esra G Ipek, Rozann Hansford, Hiroshi Ashikaga, Ronald D Berger, Joseph E Marine, David D Spragg, Harikrishna Tandri, Stefan L Zimmerman, Henry Halperin, Scott Brancato, Hugh Calkins, Charles Henrikson, Saman Nazarian
Standard Ablation Versus Magnetic Resonance Imaging-Guided Ablation In The Treatment Of Ventricular Tachycardia., Tarek Zghaib, Esra G Ipek, Rozann Hansford, Hiroshi Ashikaga, Ronald D Berger, Joseph E Marine, David D Spragg, Harikrishna Tandri, Stefan L Zimmerman, Henry Halperin, Scott Brancato, Hugh Calkins, Charles Henrikson, Saman Nazarian
Articles, Abstracts, and Reports
No abstract provided.
Psychiatric Impact Of Tuberous Sclerosis Complex And Utilization Of Mental Health Treatment, Kate Mowrey, Hope Northrup Md